KIR3DL2 and T-cell non-Hodgkin lymphoma: Apart from SpA, KIR3DL2 expression delineates both circulating and infiltrating T cell lymphoma cells in Sézary’s syndrome (SS; Musette et al., 2003; Poszepczynska-Guigne et al., 2004).